CAF-DCF A HUMAN TO HUMAN APPROACH Logo (EUIPO, 02/24/2016)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark CAF-DCF A HUMAN TO HUMAN APPROACH was filed as Figurative mark on 02/24/2016 at the European Union Intellectual Property Office.
It was registered as a trademark on 06/23/2016.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Drops #Bottles or flasks in circular or elliptical horizontal cross section #Other geometrical figures, indefinable designs
| Trademark form | Figurative mark |
| File reference | 015142953 |
| Application date | February 24, 2016 |
| Publication date | March 16, 2016 |
| Entry date | June 23, 2016 |
| Expiration date | February 24, 2026 |
Trademark owner
Tour W - 102 Terrasse Boieldieu -19 ème Etage
92800 Puteaux
FR
92800 Puteaux
FR
Trademark representatives
29 bis rue d'Astorg
75008 Paris
FR
goods and services
5
Medical and veterinary preparations and articles; Pharmaceuticals and natural remedies; Anti-infectives; Antibacterial pharmaceuticals; Biopharmaceuticals for the treatment of cancer; Cardiovascular pharmaceuticals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical preparations for the prevention of diseases caused by bacteria; Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the prevention of autoimmune disorders; Pharmaceutical preparations for the treatment of autoimmune disorders; Pharmaceutical preparations for the prevention of disorders of the immune system; Pharmaceutical preparations for the prevention of disorders of the nervous system; Pharmaceutical preparations for the prevention of diseases of the musculo-skeletal system; Pharmaceutical preparations for the prevention of diseases of the nervous system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for the prevention of diseases of the immune system; Pharmaceutical preparations for the prevention of disorders of the musculo-skeletal system; Pharmaceutical preparations for the prevention of disorders of the respiratory system; Pharmaceutical preparations for the prevention of inflammatory disorders; Pharmaceutical preparations for use in organ transplantation; Pharmaceutical preparations for use in hematology; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; Pharmaceutical preparations for the treatment of cardiovascular disease; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of multiple sclerosis; Pharmaceutical preparations for the treatment of bone diseases; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations for human use; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Medicines for human purposes; Pharmaceutical preparations; Pharmaceutical preparations and substances for use in the field of anesthesia; Pharmaceutical preparations and substances; Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for use in gynecology; Anti-viral agents; Pharmaceutical preparations and substances with anti-inflammatory properties; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical products for the treatment of infectious diseases; Immunomodulators; Immunotherapeutic agents for bacterial infections; Human immune globulin; Anti-inflammatories; Human plasma protein; Haemostatic preparations; Sterile solutions for medical purposes; Human coagulation factors
35
Business assistance, management and administrative services; Commercial trading and consumer information services; Advertising, marketing and promotional services; Business analysis, research and information services; Distribution of advertising, marketing and promotional material; Advertising, marketing and promotional consultancy, advisory and assistance services; Public relations services; Trade show and exhibition services; Loyalty, incentive and bonus program services; Product demonstrations and product display services; Provision of advertising space, time and media
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| January 9, 2024 | Transfer / Change of address, Published | ||
| December 21, 2023 | Change Representative, Published | ||
| July 12, 2016 | Transfer / Change of address, Published |
ID: 11015142953